At the heart of the review is a striking discrepancy in the experimental literature. Studies that calibrate exposure using environmentally realistic concentrations of microplastics between 10 and 500 micrometers — the size range most commonly detected in water, soil and air surveys — generally report low inflammation and low toxicity in immune cells. But when researchers use much smaller particles, from 0.5 to 5 micrometers down to nanoplastics below 1 micrometer, at comparable mass concentrations, inflammation and toxicity appear consistently in both in vivo and in vitro models. The reason is geometric: at a fixed mass, smaller particles present vastly more total surface area for interaction with biological membranes, dramatically raising the probability of uptake by immune cells. Experiments built on small, pristine, uniformly spherical particles therefore overstate the interaction between biointerfaces and plastic surfaces relative to real-world exposure, where larger, weathered fragments dominate the measured particle population.

The authors ground this argument in hard environmental numbers. Wastewater treatment plant effluents can carry up to 100,000 microplastic items per liter, while large groundwater systems show negligible contamination. Agricultural soils amended with sewage sludge and covered with plastic mulch can reach 10,000 items per kilogram, with potential consequences for soil fertility. Indoor air is a particular concern: microplastic fallout in homes ranges from 1,200 to 11,130 items per square meter per day, far exceeding outdoor deposition of 118 to 602 items per square meter per day, a disparity driven by household dust and synthetic textiles. These figures underscore that human exposure is chronic, diffuse and dominated by the indoor environment — yet they also show that most of what we inhale and ingest sits in the larger size fractions, where immune clearance mechanisms appear well suited to cope.

That capacity for clearance is a central theme of the review. Throughout human evolutionary history, the immune system has confronted a constant rain of particulate matter — volcanic ash, mineral dust, combustion by-products — and has developed layered defenses to handle it, including mucociliary clearance in the respiratory tract and phagocytic scavenging by macrophages in tissues. Unlike pathogenic microbes, which actively deploy evasion strategies and replicate inside the body, microplastics are comparatively inert, incapable of eluding immune detection or multiplying. In immunological terms, this places them closer to ordinary nuisance dust than to invading organisms. The immune response to an inert particle typically falls into one of three categories: ignorance or tolerance, recognition followed by elimination or encapsulation, or — in rare cases — pathological inflammation.

Polymer identity matters as much as particle size. The review highlights that polyethylene, one of the most abundant plastics in the environment, is structurally similar to natural polymers such as plant cuticular waxes, compounds that living organisms have long evolved to encounter and metabolize. This molecular kinship suggests that polyethylene microplastics probably display low toxicity. By contrast, synthetic polymers whose structures are unlike anything found in nature — including, potentially, certain polyester and polystyrene formulations that dominate toxicological studies — are expected to provoke stronger responses, though the authors stress that these polymer-specific differences remain poorly studied. The finding has practical implications: not all microplastics are equivalent, and treating them as a single toxicological class obscures the real risk landscape.

Complicating matters further is the phenomenon of the “bio-corona.” Once released, microplastics adsorb minerals, organic matter, microorganisms and other pollutants onto their surfaces, and aging intensifies this process by carving nanometric cracks and wrinkles into the plastic, increasing surface roughness and adsorption capacity. By the time an environmental microplastic enters the body, it wears a dynamic coat of proteins, lipids and organic molecules that may harbor pathogens or toxins. It is this coating, the authors argue, that largely determines how immune cells recognize the particle — driving either tolerance, engulfment and elimination, or, occasionally, damaging inflammation. This means laboratory studies conducted in clean buffer solutions are missing the decisive chemistry; realistic in vitro experiments must incorporate biological fluids to allow corona formation. Previous research has even shown that microplastics can interact with viruses, including SARS-CoV-2, potentially facilitating host cell infection.

Chemical additives add another layer of complexity. In many cases, the adverse effects attributed to microplastics do not come from the polymer backbone at all, but from additives leaching out of it: metallic polymerization catalysts, stabilizers, plasticizers and flame retardants, many of which are known endocrine disruptors or cytotoxins. Sunlight makes things worse — photo-oxidation continuously generates small organic molecules from the polymer itself, some of them harmful volatile compounds released from degraded plastic debris. Toxicity, in other words, is a moving target that changes as a particle weathers, fragments and sheds its chemical cargo. The review calls for toxicological experiments on environmentally relevant, aged microplastics to disentangle these overlapping contributions, rather than relying on pristine laboratory spheres.

The most formidable technical barrier is size itself. Nanoplastics — fragments below 1 micrometer — are believed to be more numerous than microplastics, more capable of crossing biological barriers and therefore potentially more dangerous. Yet they are nearly invisible to standard analytical methods. Light-based spectroscopy techniques such as infrared and Raman spectroscopy have spatial resolution limits of roughly 10 micrometers, meaning an entire class of particles escapes routine detection and quantification. Nanoplastics also tend to form large hetero-aggregates, which can generate false negatives, and their analysis demands complex sample pretreatment that is often incompatible with real environmental or biological samples. False positives, meanwhile, plague atmospheric, water and soil measurements. The result is an evidence base with large systematic uncertainties, making it extremely difficult to design immunotoxicity experiments calibrated on genuine environmental observations.

Where does this leave the question in the title — do microplastics affect human immune defenses? The honest answer, the authors conclude, is that nobody yet knows for certain. Microplastics have been detected in human organs, tissues and fluids, and studies have shown they can alter inflammatory responses, induce oxidative stress and disrupt gut microbiota homeostasis in experimental systems. But key parameters of human exposure remain unknown: the true dose reaching the body, the fraction that crosses epithelial barriers, and the extent to which particles actually enter blood circulation. The immune system, refined by millennia of confrontation with inert particulates, may simply process microplastics like any other dust. Or it may not — particularly for the smallest particles and the most chemically foreign polymers, which current methods cannot adequately track.

What the review offers is not reassurance but a roadmap. Future studies must use environmentally realistic particle sizes and concentrations, incorporate bio-corona formation, distinguish between polymers on the basis of their structural similarity to natural compounds, account for additive leaching and weathering, and push analytical frontiers toward reliable nanoplastic detection. Until then, the gap between public perception and scientific evidence will persist — and the particles, now measurable in the air of our living rooms at thousands per square meter each day, will keep accumulating in the environments we inhabit, waiting for science to catch up with their chemistry.

Microplastics are generally defined as plastic particles smaller than five millimetres, although the term covers a wide range of shapes, chemical compositions and sizes. Some are deliberately manufactured for use in products, while others form when larger plastic items deteriorate. These particles can be transported through water, air and soil, allowing them to spread far beyond the location where they were produced or discarded. Researchers have detected plastic fragments in remote environments, demonstrating the persistence and mobility of synthetic polymers across the planet.

The white paper, titled Microplastics: Preparing for Australia’s Next Regulatory Shift, distinguishes between primary and secondary microplastics. Primary microplastics are intentionally added to products such as cosmetics, paints and cleaning products, where they may serve as abrasives, fillers, texture modifiers or delivery agents. Secondary microplastics are created when larger plastic materials break apart through ultraviolet radiation, heat, mechanical abrasion and chemical weathering. A plastic bag degrading in landfill, synthetic clothing releasing fibres during washing or vehicle tyres wearing down on roads can all contribute to secondary microplastic pollution.

The scale of the challenge is connected to the extraordinary growth of global plastic production. According to the white paper, annual production has already surpassed 450 million tonnes and could approach 1.2 billion tonnes under a business-as-usual scenario. Every stage of the plastic lifecycle can generate particles, from manufacturing and transport to consumer use, recycling and disposal. Even when plastic products remain visually intact, microscopic particles can be released through friction, washing, weathering or industrial processing, creating a pollution pathway that is difficult to detect without specialised monitoring.

Scientists are still investigating the full consequences of microplastic exposure, but the available evidence has intensified concern about potential effects on human health and ecosystems. Particles may be inhaled, swallowed or transferred through food and drinking water. Their biological effects can depend on size, shape, surface chemistry and the additives or contaminants attached to them. Some particles may trigger inflammation or cellular stress, while nanoplastics—particles even smaller than microplastics—can interact with biological barriers in ways that remain poorly understood. Researchers caution that uncertainty does not mean the risks are negligible; rather, it reflects the difficulty of measuring exposure across complex environments.

The UTS authors argue that many businesses remain unaware of how deeply plastics are embedded in their operations. Their analysis of 33 handwash products sold in Australian supermarkets found that approximately one-third contained either probable microplastics or synthetic polymers. The finding illustrates why examining only a product’s visible packaging may provide an incomplete picture. Ingredients, coatings, manufacturing aids, cleaning processes, textiles, transport materials and waste streams can all create potential sources of plastic particles, even when a company does not market its products as plastic-based.

Regulation is already beginning to reshape that landscape. The European Union, several states in the United States and countries in South-East Asia have introduced restrictions aimed at reducing specific forms of microplastic pollution. Measures may target intentionally added particles, single-use plastics, product ingredients, packaging or industrial emissions. Australia’s restrictions on single-use plastic bags represent an early stage of a broader policy direction, according to the white paper’s authors. As scientific monitoring improves, businesses may increasingly be expected to identify, measure and disclose plastic pollution associated with their products and supply chains.

That shift could have consequences extending well beyond compliance costs. Companies unable to demonstrate where plastic materials enter their operations may face supply-chain disruption, changing procurement requirements and difficulty responding to new reporting rules. Consumer-facing brands could also encounter reputational damage if environmental claims are not supported by measurable reductions. The distinction between genuine progress and greenwashing is likely to become increasingly important as customers, investors and regulators demand evidence about the materials used in products and the pollution generated during their lifecycles.

The white paper recommends that businesses begin preparing before regulation forces them to act. Improved monitoring and transparent reporting can help companies identify high-risk processes, while circular business models may reduce dependence on virgin plastic. Recycled-content products, alternative materials and manufacturing innovations could also limit the creation of new plastic waste, although recycled materials must themselves be assessed for quality, safety and potential particle release. Companies that align marketing claims with verifiable reduction commitments may be better positioned to build consumer trust and strengthen long-term brand value.

For Professor Martina Linnenluecke of the UTS Centre for Climate Risk and Resilience and Professor Ross Gordon of Change for Good at UTS, the central issue is not whether plastic-dependent supply chains will change, but how quickly that transformation will occur and which businesses will lead it. As detection technologies become more sensitive and public awareness grows, microplastics may emerge as one of the defining environmental tests for corporate responsibility. Companies that treat the issue as a narrow waste-management problem could find themselves unprepared for a future in which microscopic pollution becomes a visible measure of sustainability.

Subject of Research: Microplastic pollution, business supply-chain risk, consumer awareness and emerging regulation in Australia.

Article Title: Microplastics: Preparing for Australia’s Next Regulatory Shift

News Publication Date: 5-Aug-2026

Web References: https://doi.org/10.71741/4pyxmbnjaq.32583060

References: Microplastics: Preparing for Australia’s Next Regulatory Shift, UTS Business School white paper, DOI: 10.71741/4pyxmbnjaq.32583060

Keywords: microplastics, plastic pollution, environmental health, supply chains, Australia, regulation, sustainability, consumer awareness, synthetic polymers, corporate risk